When to withhold antihypertensive (blood pressure) medications in pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Blood pressure medications in pediatric patients should be withheld when the child's blood pressure is significantly below their target range, typically if systolic blood pressure is less than 70 + (2 × age in years) mmHg or if the child is experiencing symptoms of hypotension such as dizziness, lightheadedness, or syncope, as recommended by the U.S. Preventive Services Task Force 1.

Key Considerations

  • The decision to withhold antihypertensive medications should be based on the individual child's condition and medical history.
  • Common antihypertensive medications used in children include ACE inhibitors (like enalapril, lisinopril), calcium channel blockers (amlodipine), and beta-blockers (propranolol, metoprolol) 1.
  • These medications should also be temporarily withheld if the child is experiencing acute illness with dehydration, vomiting, or diarrhea, as these conditions can exacerbate hypotension.
  • Additionally, hold blood pressure medications before surgical procedures as directed by the anesthesiologist, usually 12-24 hours before surgery.

Monitoring and Resuming Treatment

  • After holding medication, it's essential to monitor the child's blood pressure closely and resume treatment once blood pressure returns to target range and any acute illness resolves.
  • The rationale for holding these medications is to prevent dangerous hypotension, which can lead to inadequate perfusion of vital organs, particularly the brain and kidneys, potentially causing organ damage in developing children.

Evidence-Based Recommendations

  • The U.S. Preventive Services Task Force recommends that medications are not used as first-line therapy for stage 1 hypertension in children, but rather lifestyle interventions such as weight reduction, increased physical activity, and restricted sodium intake 1.
  • The American Academy of Pediatrics also provides guidance on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents, including recommendations for antihypertensive medication use 1.

From the FDA Drug Label

The usual recommended starting dose is 0. 08 mg/kg (up to 5 mg) once daily. Dosage should be adjusted according to blood pressure response. Enalapril maleate is not recommended in neonates and in pediatric patients with glomerular filtration rate <30 mL/min/1. 73 m 2, as no data are available. The effective antihypertensive oral dose in pediatric patients ages 6 to 17 years is 2.5 mg to 5 mg once daily. Doses in excess of 5 mg daily have not been studied in pediatric patients

Withholding Antihypertensive Medications in Pediatric Patients:

  • Neonates: Withhold antihypertensive medications, such as enalapril, as no data are available.
  • Pediatric patients with glomerular filtration rate <30 mL/min/1. 73 m 2: Withhold antihypertensive medications, such as enalapril, as no data are available.
  • Hypotension: Withhold or adjust antihypertensive medications if hypotension occurs. 2 3

From the Research

Withholding Antihypertensive Medications in Pediatric Patients

  • There is no direct evidence to suggest when to withhold antihypertensive medications in pediatric patients 4, 5, 6, 7, 8.
  • However, studies suggest that lifestyle modifications such as weight management, dietary changes, and daily physical activity can be effective in lowering blood pressure in pediatric patients, and may be considered before initiating antihypertensive medication 4.
  • The decision to withhold antihypertensive medication in pediatric patients may depend on various factors, including the severity of hypertension, the presence of underlying medical conditions, and the patient's response to lifestyle modifications.
  • Further research is needed to determine the optimal approach to managing hypertension in pediatric patients, including the use of antihypertensive medications and lifestyle modifications 5, 6.

Considerations for Antihypertensive Medication Use in Pediatric Patients

  • Antihypertensive medications such as angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, calcium channel blockers, and beta-blockers may be effective in lowering blood pressure in pediatric patients 5, 6, 7, 8.
  • However, the use of these medications in pediatric patients should be carefully considered, taking into account the potential risks and benefits, as well as the availability of alternative treatments such as lifestyle modifications 4, 5, 6.
  • The choice of antihypertensive medication and the decision to withhold medication should be individualized based on the patient's specific needs and circumstances 5, 6, 7, 8.

Related Questions

What are the causes and management of pediatric hypertension (high blood pressure)?
What is the next step in managing a 38-year-old female with uncontrolled hypertension (HTN) despite being on amlodipine (calcium channel blocker) 2.5 mg/day?
What is the recommended initial antihypertensive medication for a 40-year-old African-American female with newly diagnosed hypertension (elevated blood pressure), normal laboratory results, and no comorbidities such as hyperlipidemia or diabetes?
What is the next best step for a 51-year-old patient with hypertension (HTN) on Amlodipine (Norvasc) 10mg who presents with a headache and has a blood pressure of 220/110?
What is the next best step for a 26-year-old female patient with uncontrolled essential hypertension on amlodipine (calcium channel blocker) 10mg daily and metoprolol (beta blocker) 50mg daily, with a blood pressure of 146/90 mmHg?
What is the mechanism of action of Abciximab (Abciximab is a Glycoprotein IIb/IIIa receptor antagonist)?
Can hypermagnesemia cause palpitations?
What is the recommended dose adjustment for Clozapine (Clozaril) after reaching a daily dose of 500 milligrams?
Can activation of the NLRP3 (Nucleotide-binding domain, Leucine-rich repeat-containing family, Pyrin domain-containing 3) inflammasome cause Multiple Sclerosis (MS)?
Can activation of the NLRP3 (Nucleotide-binding domain, Leucine-rich repeat-containing family, Pyrin domain-containing 3) inflammasome cause Multiple Sclerosis (MS)?
Can an activated NLRP3 (Nucleotide-binding domain, leucine-rich repeat-containing family, pyrin domain-containing 3) inflammasome cause sarcoidosis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.